Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_15d42f684941d5b0617ca7764ebdff07 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-113 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K48-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-06 |
filingDate |
2011-12-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2a6d67230d113b367e2b29b78e8ff144 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_52d17fe3ef7db92565fd5277b98acacc http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4ce4802f445fcef7407307d523de9030 |
publicationDate |
2012-01-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
AU-2011254024-A1 |
titleOfInvention |
Antisense Modulation of Apolipoprotein B Expression |
abstract |
Methods for the rapid and long-term lowering of lipid levels in human subjects and for the treatment of conditions associated with elevated LDL-cholesterol and elevated apolipoprotein B are provided. WO 2006/020676 PCT/US2005/028342 Figure 1 p= 0.0002 p= 0.0002 p< 0.0001 -20 00 0 90 > 0 o 00 .)000 0 0 0 -0 0 0 0 0 ; 0 -60 -100 1 1 Trough AUC (pg*hrlmL) |
priorityDate |
2004-08-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |